Costentin CE - Search Results

1

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.

Faivre S, Santoro A, Kelley RK, Gane E, Costentin CE, Gueorguieva I, Smith C, Cleverly A, Lahn MM, Raymond E, Benhadji KA, Giannelli G. Faivre S, et al. Among authors: costentin ce. Liver Int. 2019 Aug;39(8):1468-1477. doi: 10.1111/liv.14113. Epub 2019 Jun 3. Liver Int. 2019. PMID: 30963691 Clinical Trial.

2

Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study.

Barrault C, Alqallaf S, Lison H, Lamote-Chaouche I, Bourcier V, Laugier J, Thevenot T, Labarriere D, Ripault MP, Le Gruyer A, Costentin C, Behar V, Hagege H, Jung C, Cadranel JF; ANGH OBADE Group. Barrault C, et al. Alcohol Alcohol. 2023 Mar 10;58(2):117-124. doi: 10.1093/alcalc/agac065. Alcohol Alcohol. 2023. PMID: 36527321

3

Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients.

Canivet CM, Zheng MH, Qadri S, Vonghia L, Chuah KH, Costentin C, George J, Armandi A, Adams LA, Lange NF, Blanchet O, Moal V, Younes R, Roux M, Chan WK, Sturm N, Eslam M, Bugianesi E, Wang Z, Dufour JF, Francque S, Yki-Järvinen H, Zheng KI, Boursier J. Canivet CM, et al. Clin Gastroenterol Hepatol. 2023 Nov;21(12):3097-3106.e10. doi: 10.1016/j.cgh.2023.03.032. Epub 2023 Apr 7. Clin Gastroenterol Hepatol. 2023. PMID: 37031715 Free article.

4

Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma.

Blanchet B, Hurtova M, Roudot-Thoraval F, Costentin CE, Barrault C, Jouault H, Medkour F, Laurent A, Duvoux C, Hulin A. Blanchet B, et al. Among authors: costentin ce. Liver Int. 2009 Sep;29(8):1152-7. doi: 10.1111/j.1478-3231.2009.02084.x. Epub 2009 Jul 10. Liver Int. 2009. PMID: 19619265

5

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.

Nault JC, Pigneur F, Nelson AC, Costentin C, Tselikas L, Katsahian S, Diao G, Laurent A, Mallat A, Duvoux C, Luciani A, Decaens T. Nault JC, et al. Dig Liver Dis. 2015 Oct;47(10):869-76. doi: 10.1016/j.dld.2015.07.001. Epub 2015 Jul 10. Dig Liver Dis. 2015. PMID: 26211871

6

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group. Costentin CE, et al. Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24. Liver Int. 2017. PMID: 28199760

7

Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

Menahem B, Lubrano J, Duvoux C, Mulliri A, Alves A, Costentin C, Mallat A, Launoy G, Laurent A. Menahem B, et al. Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Liver Transpl. 2017. PMID: 28295992 Review.

8

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

Costentin CE, Decaens T, Laurent A, Nault JC, Paule B, Letoublon C, Luciani A, Calderaro J, Adam R, Bricault I, Amaddeo G, Cherqui D, Mallat A, Samuel D, Duvoux C, Ganne-Carrié N, Roudot-Thoraval F, Vibert E. Costentin CE, et al. Liver Int. 2017 Dec;37(12):1869-1876. doi: 10.1111/liv.13491. Epub 2017 Jul 13. Liver Int. 2017. PMID: 28609020

9

Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis.

Costentin CE, Minoves M, Kotzki S, Farges O, Goutté N, Decaens T, Bailly S. Costentin CE, et al. Liver Int. 2022 Jul;42(7):1638-1647. doi: 10.1111/liv.15256. Epub 2022 May 11. Liver Int. 2022. PMID: 35324065 Free PMC article.

10

ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.

Costentin C, Audureau E, Park YN, Langella S, Vibert E, Laurent A, Cauchy F, Scatton O, Chirica M, Rhaiem R, Boleslawski E, di Tommaso L, Ferrero A, Yano H, Akiba J, Donadon M, Nebbia M, Detry O, Honoré P, Di Martino M, Schwarz L, Barbier L, Nault JC, Rhee H, Lim C, Brustia R, Paradis V, Guettier C, Le Bail B, Okumura S, Blanc JF, Calderaro J. Costentin C, et al. Liver Int. 2023 Nov;43(11):2538-2547. doi: 10.1111/liv.15683. Epub 2023 Aug 14. Liver Int. 2023. PMID: 37577984 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page